Literature DB >> 2563266

Replication of the human immunodeficiency virus 1 and impaired differentiation of T cells after in vitro infection of bone marrow immature T cells.

Y Lunardi-Iskandar1, M T Nugeyre, V Georgoulias, F Barré-Sinoussi, C Jasmin, J C Chermann.   

Abstract

HIV-1 infection in vitro of normal bone marrow mononuclear cells (BMMC) depleted of mature T cells was studied. BMMC depleted of either CD3, CD2, or both could replicate HIV-1 irrespective of the presence of macrophages/monocytes. Infected bone marrow cells were shown to differentiate during the culture into CD3+, CD4+, CD8+, and CD1+ cells, whereas noninfected BMMC gave rise to CD3+, CD4+, and CD8+ cells. Moreover, 9-14% of the cells also expressed the viral proteins p24 and gp120 on their surface. Double staining studies revealed that 72 and 83% of the CD4+ cells expressed the gp120 and p24, respectively, suggesting that virus replication occurred in CD4+ cells. T cell colony growth from infected BMMC, either unfractionated or depleted of mature T cells, was impaired in a time-dependent manner, and the differentiation capacity of T cell precursors was abnormal. Colony cells displayed an immature cell phenotype (CD1+ cells) and the viral proteins gp120 and/or p24 could also be detected on CD1+ cells. In addition, pooled colony cells derived from infected CD2- and CD3-depleted BMMC could infect normal mitogen-activated lymphocytes in coculture experiments. These findings strongly suggest that HIV-1 can infect immature bone marrow T cells and be transmitted to the progeny, but the massive viral replication occurs only when the cells differentiate toward CD4+ cells.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2563266      PMCID: PMC303721          DOI: 10.1172/JCI113924

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  30 in total

1.  Colony formation by human T lymphocytes in agar medium.

Authors:  M H Claësson; M B Rodger; G R Johnson; S Whittingham; D Metcalf
Journal:  Clin Exp Immunol       Date:  1977-06       Impact factor: 4.330

2.  Defective in vitro T cell colony formation in the acquired immunodeficiency syndrome.

Authors:  A Winkelstein; R S Klein; T L Evans; B W Dixon; W L Holder; L D Weaver
Journal:  J Immunol       Date:  1985-01       Impact factor: 5.422

Review 3.  The differentiation and function of human T lymphocytes.

Authors:  E L Reinherz; S F Schlossman
Journal:  Cell       Date:  1980-04       Impact factor: 41.582

4.  Adaptation of lymphadenopathy associated virus (LAV) to replication in EBV-transformed B lymphoblastoid cell lines.

Authors:  L Montagnier; J Gruest; S Chamaret; C Dauguet; C Axler; D Guétard; M T Nugeyre; F Barré-Sinoussi; J C Chermann; J B Brunet
Journal:  Science       Date:  1984-07-06       Impact factor: 47.728

5.  The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus.

Authors:  A G Dalgleish; P C Beverley; P R Clapham; D H Crawford; M F Greaves; R A Weiss
Journal:  Nature       Date:  1984 Dec 20-1985 Jan 2       Impact factor: 49.962

6.  AIDS and lymphadenopathy syndrome (LAS) patients display similar abnormal in vitro proliferation and differentiation of T-colony forming cells (T-CFC).

Authors:  Y Lunardi Iskandar; V Georgoulias; W Rozenbaum; D Vittecoq; P Meyer; M Gentilini; C Jasmin
Journal:  Cancer Detect Prev Suppl       Date:  1987

7.  Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS).

Authors:  F Barré-Sinoussi; J C Chermann; F Rey; M T Nugeyre; S Chamaret; J Gruest; C Dauguet; C Axler-Blin; F Vézinet-Brun; C Rouzioux; W Rozenbaum; L Montagnier
Journal:  Science       Date:  1983-05-20       Impact factor: 47.728

8.  Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS.

Authors:  M Popovic; M G Sarngadharan; E Read; R C Gallo
Journal:  Science       Date:  1984-05-04       Impact factor: 47.728

9.  Human immunodeficiency virus in brain biopsies of patients with AIDS and progressive encephalopathy.

Authors:  F Gyorkey; J L Melnick; P Gyorkey
Journal:  J Infect Dis       Date:  1987-05       Impact factor: 5.226

10.  Efficient isolation and propagation of human immunodeficiency virus on recombinant colony-stimulating factor 1-treated monocytes.

Authors:  H E Gendelman; J M Orenstein; M A Martin; C Ferrua; R Mitra; T Phipps; L A Wahl; H C Lane; A S Fauci; D S Burke
Journal:  J Exp Med       Date:  1988-04-01       Impact factor: 14.307

View more
  10 in total

Review 1.  B cell responses to HIV and the development of human monoclonal antibodies.

Authors:  J E Boyd; K James
Journal:  Clin Exp Immunol       Date:  1992-05       Impact factor: 4.330

2.  Gastrointestinal epithelium is an early extrathymic site for increased prevalence of CD34(+) progenitor cells in contrast to the thymus during primary simian immunodeficiency virus infection.

Authors:  J J Mattapallil; Z Smit-McBride; S Dandekar
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

3.  Simian immunodeficiency virus infection of macaque bone marrow macrophages correlates with disease progression in vivo.

Authors:  M Kitagawa; A A Lackner; D J Martfeld; M B Gardner; S Dandekar
Journal:  Am J Pathol       Date:  1991-04       Impact factor: 4.307

4.  In vitro suppression of normal human bone marrow progenitor cells by human immunodeficiency virus.

Authors:  H N Steinberg; C S Crumpacker; P A Chatis
Journal:  J Virol       Date:  1991-04       Impact factor: 5.103

Review 5.  Nature, nurture and HIV: The effect of producer cell on viral physiology.

Authors:  Sergey Iordanskiy; Steven Santos; Michael Bukrinsky
Journal:  Virology       Date:  2013-06-05       Impact factor: 3.616

6.  Effect of phorbol myristate acetate on T cell colony formation, interleukin-2 (IL-2) receptor expression and IL-2 production by cells from patients at all stages of HIV infection.

Authors:  M Allouche; Y Lunardi-Iskandar; C Varela-Millot; M Itzhaki; P Cornuet; P Meyer; C Jasmin; V Georgoulias
Journal:  Clin Exp Immunol       Date:  1990-08       Impact factor: 4.330

7.  Biological and biochemical characterization of a factor produced spontaneously by adherent cells of human immunodeficiency virus-infected patients inhibiting interleukin-2 receptor alpha chain (Tac) expression on normal T cells.

Authors:  A Ammar; C Cibert; A M Bertoli; V Tsilivakos; C Jasmin; V Georgoulias
Journal:  J Clin Invest       Date:  1991-06       Impact factor: 14.808

8.  Hematopoietic target cells of anemogenic subgroup C versus nonanemogenic subgroup A feline leukemia virus.

Authors:  G A Dean; P M Groshek; J I Mullins; E A Hoover
Journal:  J Virol       Date:  1992-09       Impact factor: 5.103

9.  Two subpopulations of human triple-negative thymic cells are susceptible to infection by human immunodeficiency virus type 1 in vitro.

Authors:  H Valentin; M T Nugeyre; F Vuillier; L Boumsell; M Schmid; F Barré-Sinoussi; R A Pereira
Journal:  J Virol       Date:  1994-05       Impact factor: 5.103

10.  Abnormal in vitro proliferation and differentiation of T cell colony-forming cells in patients with tropical spastic paraparesis/human T lymphocyte virus type I (HTLV-I)-associated myeloencephalopathy and healthy HTLV-I carriers.

Authors:  Y Lunardi-Iskandar; A Gessain; V H Lam; R C Gallo
Journal:  J Exp Med       Date:  1993-03-01       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.